A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2011
12/08/2011	US20110301250 Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
12/08/2011	US20110301239 Use of novel lipid mediators to inhibit angiogenesis
12/08/2011	US20110301235 Organoselenium compounds and uses thereof
12/08/2011	US20110301228 Gene therapy vector for treatment of steroid glaucoma
12/08/2011	US20110301215 Inhibitors of plasma kallikrein
12/08/2011	US20110301211 Antagonists of lysophosphatidic acid receptors
12/08/2011	US20110301190 Polymorphic forms of a gabaa agonist
12/08/2011	US20110301164 Method of administering ophthalmic fluids
12/08/2011	US20110301163 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
12/08/2011	US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011	US20110301148 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
12/08/2011	US20110301125 Method for Treating Macular Degeneration
12/08/2011	US20110301122 Heteroaromatic compounds for use as hif inhibitors
12/08/2011	US20110301113 Pyridineamine derivatives
12/08/2011	US20110301112 Fused ring thrombin receptor antagonists
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301077 Method for production of lactoferrin
12/08/2011	US20110300195 Ophthalmic Compositions Comprising Calcineurin Inhibitors or mTOR Inhibitors
12/08/2011	US20110300184 Pharmaceutical compositions for treating or preventing bone conditions
12/08/2011	US20110300166 Vaccine Compositions for Inducing Immune Responses Against Components of Drusen
12/08/2011	US20110300160 Sulfation of wnt pathway proteins
12/08/2011	US20110300157 Metalloproteinase 9 and metalloproteinase 2 binding proteins
12/08/2011	US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/08/2011	US20110300136 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
12/08/2011	US20110300133 Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis
12/08/2011	US20110300125 Compositions and methods for combined therapy of disease
12/08/2011	US20110300123 Pharmacological vitreolysis
12/08/2011	US20110300115 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence
12/08/2011	US20110300097 Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
12/08/2011	DE102010022567A1 Zubereitung Preparation
12/08/2011	CA2801535A1 Composition and method for inner ear sensory hair cell regeneration or replacement
12/08/2011	CA2801417A1 Optically active dibenzylamine derivative, and method for preparing thereof
12/08/2011	CA2801145A1 N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
12/07/2011	EP2392579A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
12/07/2011	EP1802291B1 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
12/07/2011	EP1542536B1 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
12/07/2011	CN1494425B 用作治疗剂的羧酰胺衍生物 As therapeutic agents carboxamide derivatives
12/07/2011	CN102266604A 鼻传送装置 Nasal delivery device
12/07/2011	CN102266559A 包含替米沙坦盐和钙离子拮抗剂的药物组合物 Containing salts and calcium antagonist telmisartan pharmaceutical composition
12/07/2011	CN102266477A 一种益肝明目、滋阴补肾药物组合的制备方法 Preparation method of Liver eyesight, kidney Yin drug combination
12/07/2011	CN102266476A 一种益肝明目、滋阴补肾的药物组合 One kind of Liver eyesight, kidney Yin drug combination
12/07/2011	CN102266445A 一种具有保健和治疗功效的护眼中药组合物 Eye medicine composition with health and healing
12/07/2011	CN102266388A 一种用于2型糖尿病及并发症预防和治疗的药物组合物 A pharmaceutical composition for the prevention of type 2 diabetes and complications and treatment
12/07/2011	CN102266348A 一种眼内冲洗液及其制备方法 Washing liquid and its preparation method an intraocular
12/07/2011	CN102266329A 一种含长春西汀化合物的药物组合物及其制备方法 A pharmaceutical composition and preparation of compounds containing vinpocetine
12/07/2011	CN101982184B 一种蒲公英提取物的制备方法 One kind of dandelion extract preparation method thereof
12/07/2011	CN101773595B 清肝明目中药茶 Liver eyesight herbal tea
12/07/2011	CN101054344B 脂氧素A<sub>4</sub>类似物 Lipoxin A <sub> 4 </ sub> analogue
12/06/2011	US8071745 Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same
12/06/2011	US8071654 Inhibitors of thromboxane formation and action
12/06/2011	US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
12/06/2011	US8071635 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/06/2011	US8071120 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
12/06/2011	US8071110 Activatable clostridial toxins
12/06/2011	US8071096 Anti-C5aR antibodies and uses thereof
12/01/2011	WO2011150102A1 Cyclosporin emulsions
12/01/2011	WO2011149354A1 Mirnas involved in the blood brain barrier function
12/01/2011	WO2011149012A1 Prophylactic or therapeutic agent for retinal/choroidal denaturation diseases comprising isoquinolinesulfonyl derivative as active ingredient, prophylactic or therapeutic method for retinal/choroidal denaturation diseases, and isoquinolinesulfonyl derivative or pharmaceutically acceptable salt thereof and use thereof
12/01/2011	WO2011149011A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof
12/01/2011	WO2011149010A1 Novel indazole derivative or salt thereof, intermediate for the production of same, prophylactic or therapeutic agent for chorioretinal denaturative diseases and therapeutic method for chorioretinal denaturative diseases each utilizing same, and use of indazole derivative or salt thereof
12/01/2011	WO2011148193A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions
12/01/2011	WO2011148116A2 Modified hyaluronic acid, method for manufacturing same and uses thereof
12/01/2011	WO2011147984A1 Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
12/01/2011	WO2011147589A1 Neramexane for the treatment or prevention of inner ear disorders
12/01/2011	WO2011147528A1 Biguanide compounds and its use for treating cancer
12/01/2011	WO2011147252A1 Compound preparation and its uses for prevention and treatment of hearing impairment
12/01/2011	WO2011123489A3 Anti-cd40 antibodies
12/01/2011	US20110294897 Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion
12/01/2011	US20110294893 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
12/01/2011	US20110294891 Methods and compositions for treating opthalmic conditions with retinol derivatives
12/01/2011	US20110294890 Neramexane for the treatment or prevention of inner ear disorders
12/01/2011	US20110294880 Pharmaceutical composition containing prostaglandin
12/01/2011	US20110294868 Modulation of transthyretin expression
12/01/2011	US20110294833 Methods for Healthy Aging
12/01/2011	US20110294809 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
12/01/2011	US20110294794 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/01/2011	US20110294788 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
12/01/2011	US20110294784 Gamma secretase modulators
12/01/2011	US20110294781 Pyrazolo-pyrimidine compounds
12/01/2011	US20110294768 Ophthalmic Suspension for Ocular Use
12/01/2011	US20110294759 Once daily formulations of tetracyclines
12/01/2011	US20110294745 Solutions of lipophilic substances, especially medicinal solutions
12/01/2011	US20110294744 Cyclosporin emulsions
12/01/2011	US20110294742 Degradable clostridial toxins
12/01/2011	US20110294730 Method of treating glaucoma and intraocular hypertension
12/01/2011	US20110293734 New plant derived seed extract rich in essentially fatty acids derived from salvia hispanica l. seed: composition of matter, manufacturing process and use
12/01/2011	US20110293726 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293681 Hand sanitizing patch having an integrally bonded antimicrobial
12/01/2011	US20110293625 Inhibition of vegf-a secretion, angiogenesis and/or neoangiogenesis by sina mediated knockdown of vegf-c and rhoa
12/01/2011	US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	CA2800412A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions
11/2011
11/30/2011	EP2390327A1 siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
11/30/2011	EP2389939A1 Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
11/30/2011	EP2389924A1 An eyedrops of the deproteinized calf blood extract
11/30/2011	EP2389355A1 New crystals of a benzoylbenzeneacetamide derivative
11/30/2011	EP2389179A1 Use of deferiprone for treatment and prevention of iron-related eye disorders
11/30/2011	EP2156833B1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/30/2011	EP1904108B1 Ophthalmological formulation comprising methylsulfonylmethane and ciprofloxacin
11/30/2011	CN102264891A Th2细胞诱导用组合物和Th2型疾病的治疗组合物、以及该组合物的利用 Th2 cells induce therapeutic composition compositions and Th2-type diseases, as well as the composition of use

1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 531